Back
 IJOHNS  Vol.5 No.4 , July 2016
Role of Intratympanic Steroids in the Management of Idiopathic Sudden Sensori Neural Hearing Loss— Our Experience of 67 Cases
Abstract: Objective: To assess the outcomes of intratympanic steroids in the management of idiopathic sudden sensorineural hearing loss. Study Design: Retrospective study. Setting: Academic tertiary care medical centre. Materials and Methods: A total of 67 patients with idiopathic sudden sensorineural hearing loss were included in our study. Pre- and post-injection audiograms were taken to assess the outcomes in improvement in hearing. Hearing outcomes were assessed with respect to duration of onset of treatment and age of the patient. Improvement in the speech discrimination score was also assessed. Results: A total of 67 patients were included in our study of which unilateral cases were 59 and bilateral cases were 8. Subjectively 35 patients reported improvement in hearing after the therapy while objectively we found 44 ears [41 patients] had improvement. The mean PTA pre ITS was 62.7 and after ITS it was 56.3. Maximum improvement was noted at 2000 Hz and 1000 Hz. Conclusion: Intratympanic steroids can be offered as a first line therapy for idiopathic sudden sensorineural hearing loss as it is minimally invasive, and can be performed as an office based procedure with no systemic side effects. No major complications have been reported in our study and results have been satisfactory.
Cite this paper: S. Deenadayal, D. , Vidyasagar, D. , Bommakanti, V. , Naveen Kumar, M. , Ravi Kumar, N. and Chintha, R. (2016) Role of Intratympanic Steroids in the Management of Idiopathic Sudden Sensori Neural Hearing Loss— Our Experience of 67 Cases. International Journal of Otolaryngology and Head & Neck Surgery, 5, 174-180. doi: 10.4236/ijohns.2016.54028.
References

[1]   Wilson, W.R., Byl, F.M. and Laird, N. (1980) The Efficacy of Steroids in the Treatment of Idiopathic Sudden Hearing Loss. A Double-Blind Clinical Study. Archives of Otolaryngology, 106, 772-776.
http://www.ncbi.nlm.nih.gov/pubmed/7002129
http://dx.doi.org/10.1001/archotol.1980.00790360050013


[2]   Goravalingappa, R. and Bhattacharyya, A.K. (1997) Sudden Sensorineural Hearing Loss: An Update. Indian Journal of Otolaryngology and Head & Neck Surgery, 49, 87-91.

[3]   Hughes, G.B., Freedman, M.A., Haberkamp, T.J. and Guay, M.E. (1996) Sudden Sensorineural Hearing Loss. Otolaryngologic Clinics of North America, 29, 393-405.
http://www.ncbi.nlm.nih.gov/pubmed/8743339

[4]   Anderson, R.G. and Meyerhoff, W.L. (1983) Sudden Sensorineural Hearing Loss. Otolaryngologic Clinics of North America, 16, 189-195.
http://www.ncbi.nlm.nih.gov/pubmed/6856305

[5]   Raymundo, I.T., Bahmad, F., Barros Filho, J., Pinheiro, T.G., Maia, N.A. and Oliveira, C.A. (2015) Intratympanic Methylprednisolone as Rescue Therapy in Sudden Sensorineural Hearing Loss. Brazilian Journal of Otorhinolaryngology, 76, 499-509.
http://www.ncbi.nlm.nih.gov/pubmed/20835538
http://dx.doi.org/10.1590/S1808-86942010000400015


[6]   Newman, C.W., Jacobson, G.P. and Spitzer, J.B. (1996) Development of the Tinnitus Handicap Inventory. Archives of Otolaryngology—Head and Neck Surgery, 122, 143-148.
http://www.ncbi.nlm.nih.gov/pubmed/8630207
http://dx.doi.org/10.1001/archotol.1996.01890140029007


[7]   McCombe, A., Baguley, D., Coles, R., McKenna, L., McKinney, C. and Windle-Taylor, P. (2001) Guidelines for the Grading of Tinnitus Severity: The Results of a Working Group Commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clinical Otolaryngology and Allied Sciences, 26, 388-393.
http://www.ncbi.nlm.nih.gov/pubmed/11678946
http://dx.doi.org/10.1046/j.1365-2273.2001.00490.x


[8]   Breivik, H., Borchgrevink, P.C., Allen, S.M., et al. (2008) Assessment of Pain. British Journal of Anaesthesia, 101, 17-24.
http://dx.doi.org/10.1093/bja/aen103

[9]   Haynes, D.S., O’Malley, M., Cohen, S., Watford, K. and Labadie, R.F. (2007) Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss after Failure of Systemic Therapy. Laryngoscope, 117, 3-15.
http://dx.doi.org/10.1097/01.mlg.0000245058.11866.15

[10]   Fetterman, B.L., Luxford, W.M. and Saunders, J.E. (1996) Sudden Bilateral Sensorineural Hearing Loss. Laryngoscope, 106, 1347-1350.
http://dx.doi.org/10.1097/00005537-199611000-00008

[11]   Oh, J.-H., Park, K., Lee, S.J., Shin, Y.R. and Choung, Y.-H. (2007) Bilateral versus Unilateral Sudden Sensorineural Hearing Loss. Otolaryngology—Head and Neck Surgery, 136, 87-91.
http://dx.doi.org/10.1016/j.otohns.2006.05.015

[12]   (2016) Intratympanic Steroid Treatment in Idiopathic Sudden Sensorineural Hearing Loss. A Control Study.
http://connection.ebscohost.com/c/articles/44523848/intratympanic-steroid-treatment-as-primary-therapy-idiopathic-sudden-sensorineural-hearing-loss

[13]   Slattery, W.H., Fisher, L.M., Iqbal, Z., Friedman, R.A. and Liu, N. (2005) Intratympanic Steroid Injection for Treatment of Idiopathic Sudden Hearing Loss. Otolaryngology—Head and Neck Surgery, 133, 251-259.
http://dx.doi.org/10.1016/j.otohns.2005.05.015

[14]   Khaimook, W. and Jantarapattana, K. (2011) Therapy of Idiopathic Sudden Sensorineural Hearing Loss with Intratympanic Steroid Injection. Journal of the Medical Association of Thailand, 94, 1495-1499.
http://www.ncbi.nlm.nih.gov/pubmed/22295738

[15]   Li, P., Zeng, X.-L., Ye, J., Yang, Q.-T., Zhang, G.-H. and Li, Y. (2011) Intratympanic Methylprednisolone Improves Hearing Function in Refractory Sudden Sensorineural Hearing Loss: A Control Study. Audiology and Neurotology, 16, 198-202.
http://dx.doi.org/10.1159/000320838

[16]   Yang, H.C., Cho, Y.B., Jang, C.H. and Cho, H.-H. (2015) Efficacy of Concomitant Intratympanic Steroid Injection for Sudden Deafness According to Initial Hearing Loss. Otology & Neurotology, 36, 1604-1609.
http://dx.doi.org/10.1097/MAO.0000000000000869

[17]   Chen, Y., Wen, L., Hu, P., Qiu, J., Lu, L. and Qiao, L. (2010) Endoscopic Intratympanic Methylprednisolone Injection for Treatment of Refractory Sudden Sensorineural Hearing Loss and One Case in Pregnancy. Journal of Otolaryngology—Head & Neck Surgery, 39, 640-645.
http://www.ncbi.nlm.nih.gov/pubmed/21144358

 
 
Top